Size controlled protein nanoemulsions for active targeting of folate receptor positive cells

[Display omitted] •Stable BSA nanoemulsions are produced by high pressure homogenization.•Linear correlation is found between Poloxamer 407 levels and size of nanoemulsions.•Presence of BSA-FA conjugate results in specific FA mediated internalization in folate receptor positive cells. Bovine serum a...

Full description

Saved in:
Bibliographic Details
Published in:Colloids and surfaces, B, Biointerfaces Vol. 135; pp. 90 - 98
Main Authors: Loureiro, Ana, Nogueira, Eugénia, Azoia, Nuno G., Sárria, Marisa P., Abreu, Ana S., Shimanovich, Ulyana, Rollett, Alexandra, Härmark, Johan, Hebert, Hans, Guebitz, Georg, Bernardes, Gonçalo J.L., Preto, Ana, Gomes, Andreia C., Cavaco-Paulo, Artur
Format: Journal Article
Language:English
Published: Netherlands Elsevier B.V 01-11-2015
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[Display omitted] •Stable BSA nanoemulsions are produced by high pressure homogenization.•Linear correlation is found between Poloxamer 407 levels and size of nanoemulsions.•Presence of BSA-FA conjugate results in specific FA mediated internalization in folate receptor positive cells. Bovine serum albumin (BSA) nanoemulsions were produced by high pressure homogenization with a tri-block copolymer (Poloxamer 407), which presents a central hydrophobic chain of polyoxypropylene (PPO) and two identical lateral hydrophilic chains of polyethylene glycol (PEG). We observed a linear correlation between tri-block copolymer concentration and size – the use of 5mg/mL of Poloxamer 407 yields nanoemulsions smaller than 100nm. Molecular dynamics and fluorescent tagging of the tri-block copolymer highlight their mechanistic role on the size of emulsions. This novel method enables the fabrication of highly stable albumin emulsions in the nano-size range, highly desirable for controlled drug delivery. Folic Acid (FA)-tagged protein nanoemulsions were shown to promote specific folate receptor (FR)-mediated targeting in FR positive cells. The novel strategy presented here enables the construction of size controlled, functionalized protein-based nanoemulsions with excellent characteristics for active targeting in cancer therapy.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0927-7765
1873-4367
1873-4367
0927-7765
DOI:10.1016/j.colsurfb.2015.06.073